Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial-Reference-Cited by-同舟云学术

Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial

Published:2015-01-09 Issue:3 Volume:17 Page:276-284
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Gallwitz B.¹,Rosenstock J.²,Patel S.³,von Eynatten M.⁴,Hehnke U.⁴,Mehlburger L.⁴,Dugi K. A.⁴,Woerle H.-J.⁴

Affiliation:

1. Department of Medicine IV, Universitätsklinikum Tübingen; Tübingen Germany

2. Dallas Diabetes and Endocrine Center at Medical City; Dallas TX USA

3. Boehringer Ingelheim Ltd; Bracknell UK

4. Boehringer Ingelheim Pharma GmbH & Co. KG; Ingelheim Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12419/fullpdf

Reference45 articles.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

2. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

3. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations;Bennett;Ann Intern Med,2011

4. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes;Phung;JAMA,2010

5. Effects of intensive glucose lowering in type 2 diabetes;Gerstein;N Engl J Med,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review;World Journal of Diabetes;2022-12-15

2. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2019-04-18

3. Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes;Journal of Diabetes Investigation;2018-09-26

4. A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy;Current Medical Research and Opinion;2017-06-28

5. Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations;Journal of Diabetes Investigation;2016-07-21